BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28289666)

  • 1. Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
    Lee CR; Park S; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
    Ann Surg Treat Res; 2017 Mar; 92(3):129-135. PubMed ID: 28289666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
    Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
    Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
    Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
    Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.
    Li Z; Zhang H; Yan Y; Li X; Jia M; Zhou H; Lu X
    Front Endocrinol (Lausanne); 2023; 14():1200855. PubMed ID: 37780622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
    World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
    Cao J; Chen C; Chen C; Wang QL; Ge MH
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between BRAF
    Lu HZ; Qiu T; Ying JM; Lyn N
    Oncol Lett; 2017 Mar; 13(3):1595-1600. PubMed ID: 28454296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly.
    Wang X; Lei J; Wei T; Zhu J; Li Z
    Cancer Manag Res; 2019; 11():2371-2377. PubMed ID: 31114316
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial papillary thyroid microcarcinoma: a new clinical entity.
    Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
    Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.
    Sung TY; Lee YM; Yoon JH; Chung KW; Hong SJ
    World J Surg; 2015 Aug; 39(8):1930-5. PubMed ID: 25894401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis.
    Huang XP; Ye TT; Zhang L; Liu RF; Lai XJ; Wang L; Yang M; Zhang B; Li XY; Liu ZW; Xia Y; Jiang YX
    Surg Oncol; 2018 Jun; 27(2):172-176. PubMed ID: 29937168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 18. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
    He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
    Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    Front Endocrinol (Lausanne); 2019; 10():363. PubMed ID: 31275239
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients.
    Gu JH; Zhao YN; Xie RL; Xu WJ; You DL; Zhao ZF; Wang F; Fei J
    BMC Endocr Disord; 2019 Nov; 19(1):124. PubMed ID: 31729977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.